{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-25-005523","form_type":"8-K","ticker":"PHIO","cik":"0001533040","company_name":"Phio Pharmaceuticals Corp.","filed_at":"2025-07-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.250773+00:00","generated_at":"2026-05-17T23:00:49.042734+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Phio Pharma receives ~$2.5M from warrant exercise, issues new warrants","bullets":["Gross proceeds ~$2.5M from exercise of 928,596 warrants at $2.00 and $2.485 per share.","Holders issued new unregistered Series J (5-yr term) and Series K (24-mo term) warrants for up to 1,857,192 shares at $2.485/share.","Holders paid additional $0.125 per new warrant ($232,149 aggregate) as part of inducement.","H.C. Wainwright receives 7.5% cash fee and placement agent warrants for 69,645 shares.","Net proceeds to be used for working capital and general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-25-005523","json":"https://secwatch.observer/filing/0001683168-25-005523.json","markdown":"https://secwatch.observer/filing/0001683168-25-005523.md","text":"https://secwatch.observer/filing/0001683168-25-005523.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533040/000168316825005523/0001683168-25-005523-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533040/000168316825005523/phio_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T23:00:49.042734+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}